Dr. Ronald Hirsch of R1RCM discusses new Alzheimer's drug Leqembi with HFMA's Nick Hut
Listen now
Description
Dr. Ronald Hirsch of R1RCM discusses considerations around a new Alzheimer's drug with Senior Editor Nick Hut.
Mentioned in this episode:
CY 2024 Hospital Outpatient Prospective Payment System (OPPS) Policy Changes: Hospital Price Transparency Proposals (CMS-1786-P) | CMS
NCA - Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease (CAG-00431R) - Proposed Decision Memo (cms.gov)
More Episodes
HFMA Senior Editor Nick Hut and HFMA Policy Director Shawn Stack discuss the latest in healthcare finance news including pre-election thoughts, a new Medicare appeals process and application of the two-midnight rule.
Published 11/04/24
Published 11/04/24
Dr. Kamal Golla is back on the podcast this week discussing the financial considerations for patients and their care team after a cancer diagnosis.
Published 10/21/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
